Whalegun
Home

Jonathan Zalevsky, Chief R&D Officer: Nektar Therapeutics NKTR Planned sale · Filed 08/18

Trade details

Type
Planned sale notice
Stock
Nektar Therapeutics NKTR
Person
Jonathan ZalevskyChief R&D Officer
Planned sale date
26/08/18
Filed
26/08/18

More to sell after $13K in 3 months

Nektar Therapeutics trades, last 26 weeks

What else happened in Nektar Therapeutics around then

Filed or reported within 30 days of the trade day · 07/19~09/17

Jonathan Zalevsky's recent trades

  • Jonathan Zalevsky

    Planned sale10b5-1 planNektar Therapeutics

    $371.5K

    Filed 06/30

  • Jonathan Zalevsky

    Sell10b5-1 planNektar Therapeutics

    $336.2K

    Filed 06/17

  • Jonathan Zalevsky

    Planned sale10b5-1 planNektar Therapeutics

    $328.8K

    Filed 06/15

  • Jonathan Zalevsky

    SellNektar Therapeutics

    $13K

    Filed 05/21

  • Jonathan Zalevsky

    Planned saleNektar Therapeutics

    $13K

    Filed 05/19

Jonathan Zalevsky, Chief Officer — plans to sell 186 sh of Nektar Therapeutics NKTR · $13.4K · around 08/18 | Whalegun